nach oben

Quality of Life Research

01.06.2011

Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers

Erschienen in: Quality of Life Research | Ausgabe 5/2011

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Purpose

To assess the patterns of, and trends over time in, health-related quality of life (HRQL) reporting in randomized controlled trials (RCTs).

Methods

The English-language literature of RCTs published in 2002–2008 was identified using Medline, Embase, and Healthstar databases, in addition to the Cochrane Clinical Trials Registry. Eligible trials were phase III studies that included an HRQL outcome. Data were abstracted on eight outcomes derived from previously recommended quality standards for reporting HRQL, and on four outcomes describing how HRQL data are presented in RCT reports. Two readers examined each article; discrepancies were resolved through discussion and third review if required.

Results

A sample of 794 RCTs was identified. HRQL was a primary outcome in 25.4% (200/794). One hundred and ten RCTs (14%) used “supplementary” reports (separate from the first publication) to report HRQL findings. The proportion of RCTs that met the eight quality indicators ranged from 15% (HRQL used in the calculation of sample size) to 81% (reporting instrument validity). RCTs with HRQL as a primary outcome or with a supplementary report had higher concordance on the quality measures. Reporting improved on many indicators over time. Substantive variation in how HRQL data are presented in RCTs was evident.

Conclusions

Current practice of reporting HRQL outcomes in RCTs remains highly variable, both with regard to quality of reporting and the patterns of data analysis and presentation. This variation presents challenges for clinicians to apply these data in clinical practice. Consistent reporting practices, which are interpretable by clinicians, are required, as are processes to achieve this consistency in future reports.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Karnofsky, D. A., Abelmann, W. H., Craver, L. F., & Burchenal, J. H. (1948). The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1, 634–656.CrossRef

Steinbrocker, O., Traeger, C. H., & Batterman, R. C. (1949). Therapeutic criteria in rheumatoid arthritis. JAMA, 140(8), 659–662.

Bowling, A. (1995). Measuring disease: A review of disease-specific quality of life measurement scales. Buckingham: Open University Press.

Ellwood, P. M. (1988). Shattuck lecture-outcomes management. A technology of patient experience. New England Journal of Medicine, 318(23), 1549–1556.PubMedCrossRef

Oxman, A. D., Sackett, D. L., & Guyatt, G. H. (1993). Users’ guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. Journal of the American Medical Association, 270(17), 2093–2095.PubMedCrossRef

Staquet, M., Berzon, R., Osoba, D., & Machin, D. (1996). Guidelines for reporting results of quality of life assessments in clinical trials. Quality of Life Research, 5(5), 496–502.PubMedCrossRef

Lee, C. W., & Chi, K. N. (2000). The standard of reporting of health-related quality of life in clinical cancer trials. Journal of Clinical Epidemiology, 53(5), 451–458.PubMedCrossRef

Efficace, F., Bottomley, A., & van Andel, G. (2003). Health related quality of life in prostate carcinoma patients: A systematic review of randomized controlled trials. Cancer, 97(2), 377–388.PubMedCrossRef

Efficace, F., Bottomley, A., Osoba, D., et al. (2003). Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials–does HRQOL evaluation in prostate cancer research inform clinical decision making? Journal of Clinical Oncology, 21(18), 3502–3511.PubMedCrossRef

10.

Efficace, F., Osoba, D., Gotay, C., Sprangers, M., Coens, C., & Bottomley, A. (2007). Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Annals of Oncology, 18(4), 775–781.PubMedCrossRef

11.

Joly, F., Vardy, J., Pintilie, M., & Tannock, I. F. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18, 1935–1942.PubMedCrossRef

12.

Guyatt, G. H., Naylor, C. D., Juniper, E., Heyland, D. K., Jaeschke, R., & Cook, D. J. (1997). Users’ guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 277(15), 1232–1237.PubMedCrossRef

13.

Sprangers, M. A., Moinpour, C. M., Moynihan, T. J., Patrick, D. L., & Revicki, D. A. (2002). Assessing meaningful change in quality of life over time: A users’ guide for clinicians. Mayo Clinic Proceedings, 77(6), 561–571.PubMedCrossRef

14.

Bezjak, A., Ng, P., Skeel, R., DePetrillo, A. D., Comis, R., & Taylor, K. M. (2001). Oncologists’ use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians. Quality of Life Research, 10(1), 1–13.PubMedCrossRef

15.

Guyatt, G., & Schunemann, H. (2007). How can quality of life researchers make their work more useful to health workers and their patients? Quality of Life Research, 16, 1097–1105.PubMedCrossRef

16.

Brundage, M. D., Bezjak, A., Ringash, J., & Fleming, S. (2005). Patterns of reporting quality of life data in randomized clinical trials. San Francisco: ISOQOL. Ref Type: Abstract.

17.

Begg, C., Cho, M., Eastwood, S., et al. (1996). Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 276(8), 637–639.PubMedCrossRef

18.

SAS System for Windows [computer program]. (1989). Version 6.12. Cary, NC: SAS Institute Inc.

19.

Guyatt, G. H., Sackett, D. L., & Cook, D. J. (1993). Users’ guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 270(21), 2598–2601.PubMedCrossRef

20.

Sackett, D. L., & Cook, D. J. (1994). Users’ guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. Journal of the American Medical Association, 271(1), 59–63.PubMedCrossRef

21.

Oxman, A. D., Cook, D. J., & Guyatt, G. H. (1994). Users’ guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. Journal of the American Medical Association, 272(17), 1367–1371.PubMedCrossRef

22.

Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D., & Stephens, R. (1997). Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: The U.K. Medical Research Council experience. European Journal of Cancer, 33(1), 20–28.PubMedCrossRef

23.

Guyatt, G., Osoba, D., Wu, A., Wyrwich, K. W., & Norman, G. R. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77(4), 371–383.PubMedCrossRef

24.

Curran, C. R. (1999). Data display techniques. Applied Nursing Research, 12, 153–158.PubMedCrossRef

25.

Standing, L., Conezio, J., & Haber, R. (1970). Perception and memory for pictures: Single-trial learning of 2500 visual stimuli. Psychonomic Science, 19(2), 73–74.

26.

Feldman-Stewart, D., Kocovski, N., McConnell, B., Brundage, M., & Mackillop, W. (2000). Perception of quantitative information for treatment decisions. Medical Decision Making, 20(2), 228–238.PubMedCrossRef

27.

Brundage, M., Feldman-Stewart, D., Leis, A., et al. (2005). Communicating quality of life information to cancer patients: A study of six presentation formats. Journal of Clinical Oncology, 23(28), 6949–6956.PubMedCrossRef

28.

Bottomley, A., Flechtner, H., Efficace, F., et al. (2005). Health related quality of life outcomes in cancer clinical trials. [Review] [53 refs]. European Journal of Cancer, 41(12), 1697–1709.PubMedCrossRef

Titel: Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers
Publikationsdatum: 01.06.2011
Erschienen in: Quality of Life Research / Ausgabe 5/2011
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-010-9793-3